Identification of the Bleeding Point in Hemorrhagic Moyamoya Disease Using Fusion Images of Susceptibility-Weighted Imaging and Time-of-Flight MRA

References

1. 1.↵
   2. Han DH,
   3. Kwon OK,
   4. Byun BJ, et al

   ; Korean Society for Cerebrovascular Disease. A co-operative study: clinical characteristics of 334 Korean patients with Moyamoya disease treated at neurosurgical institutes (1976–1994). Acta Neurochir (Wien) 2000;142:1263–73 doi:10.1007/s007010070024 pmid:11201642

   CrossRefPubMed
2. 2.↵
   2. Nah HW,
   3. Kwon SU,
   4. Kang DW, et al

   . Moyamoya disease-related versus primary intracerebral hemorrhage: location and outcomes are different. Stroke 2012;43:1947–50 doi:10.1161/STROKEAHA.112.654004 pmid:22693130

   Abstract/FREE Full Text
3. 3.↵
   2. Jiang H,
   3. Yang H,
   4. Ni W, et al

   . Long-term outcomes after combined revascularization surgery in adult hemorrhagic Moyamoya disease. World Neurosurg 2018;116:e1032–41 doi:10.1016/j.wneu.2018.05.153 pmid:29859362

   CrossRefPubMed
4. 4.↵
   2. Funaki T,
   3. Takahashi JC,
   4. Houkin K, et al

   . High rebleeding risk associated with choroidal collateral vessels in hemorrhagic Moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg 2018 Feb 1:1–8. [Epub ahead of print] doi:10.3171/2017.9.JNS17576 pmid:29498573

   CrossRefPubMed
5. 5.↵
   2. Miyamoto S,
   3. Yoshimoto T,
   4. Hashimoto N, et al

   . Effects of extracranial-intracranial bypass for patients with hemorrhagic Moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 2014;45:1415–21 doi:10.1161/STROKEAHA.113.004386 pmid:24668203

   Abstract/FREE Full Text
6. 6.↵
   2. Liu X,
   3. Zhang D,
   4. Shuo W, et al

   . Long term outcome after conservative and surgical treatment of haemorrhagic Moyamoya disease. J Neurol Neurosurg Psychiatry 2013;84:258–65 doi:10.1136/jnnp-2012-302236 pmid:23012444

   Abstract/FREE Full Text
7. 7.↵
   2. Jang DK,
   3. Lee KS,
   4. Rha HK, et al

   . Bypass surgery versus medical treatment for symptomatic Moyamoya disease in adults. J Neurosurg 2017;127:492–502 doi:10.3171/2016.8.JNS152875 pmid:27834597

   CrossRefPubMed
8. 8.↵
   2. Ge P,
   3. Zhang Q,
   4. Ye X, et al

   . Clinical features, surgical treatment, and long-term outcome in children with hemorrhagic Moyamoya disease. J Stroke Cerebrovasc Dis 2018;27:1517–23 doi:10.1016/j.jstrokecerebrovasdis.2017.12.047 pmid:29567119

   CrossRefPubMed
9. 9.↵
   2. Takahashi JC,
   3. Funaki T,
   4. Houkin K

   , Trial, , et al. Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan Adult Moyamoya Trial. Stroke 2016;47:37–43 doi:10.1161/STROKEAHA.115.010819 pmid:26645256

   Abstract/FREE Full Text
10. 10.↵
    2. Kazumata K,
    3. Shinbo D,
    4. Ito M, et al

    . Spatial relationship between cerebral microbleeds, Moyamoya vessels, and hematoma in Moyamoya disease. J Stroke Cerebrovasc Dis 2014;23:1421–28 doi:10.1016/j.jstrokecerebrovasdis.2013.12.007 pmid:24529354

    CrossRefPubMed
11. 11.↵
    2. Wenz H,
    3. Wenz R,
    4. Maros M, et al

    . Incidence, locations, and longitudinal course of cerebral microbleeds in European Moyamoya. Stroke 2017;48:307–13 doi:10.1161/STROKEAHA.116.014335 pmid:28062861

    Abstract/FREE Full Text
12. 12.↵
    2. Funaki T,
    3. Takahashi JC,
    4. Houkin K, et al

    . Angiographic features of hemorrhagic Moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 2018;128:777–84 doi:10.3171/2016.11.JNS161650 pmid:28409736

    CrossRefPubMed
13. 13.↵
    2. Funaki T,
    3. Takahashi JC,
    4. Yoshida K, et al

    . Periventricular anastomosis in Moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg 2016;124:1766–72 doi:10.3171/2015.6.JNS15845 pmid:26613176

    CrossRefPubMed
14. 14.↵
    Research Committee on the Pathology Treatment of Spontaneous Occlusion of the Circle of Willis. Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of Moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 2012;52:245–66 doi:10.2176/nmc.52.245 pmid:22870528

    CrossRefPubMed
15. 15.↵
    2. Gregoire SM,
    3. Chaudhary UJ,
    4. Brown MM, et al

    . The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009;73:1759–66 doi:10.1212/WNL.0b013e3181c34a7d pmid:19933977

    Abstract/FREE Full Text
16. 16.↵
    2. Haacke EM,
    3. Xu Y,
    4. Cheng YC, et al

    . Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–18 doi:10.1002/mrm.20198 pmid:15334582

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Sehgal V,
    3. Delproposto Z,
    4. Haacke EM, et al

    . Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439–50 doi:10.1002/jmri.20404 pmid:16163700

    CrossRefPubMed
18. 18.↵
    2. Morioka M,
    3. Hamada JI,
    4. Kawano T, et al

    . Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult patients with Moyamoya disease. Stroke 2003;34:90–95 doi:10.1161/01.STR.0000047120.67507.0D pmid:12511756

    Abstract/FREE Full Text
19. 19.↵
    2. Liu W,
    3. Zhu S,
    4. Wang X, et al

    . Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult Moyamoya disease. J Clin Neurosci 2011;18:374–78 doi:10.1016/j.jocn.2010.05.032 pmid:21237656

    CrossRefPubMed
20. 20.↵
    2. Liu P,
    3. Han C,
    4. Li DS, et al

    . Hemorrhagic Moyamoya disease in children: clinical, angiographic features, and long-term surgical outcome. Stroke 2016;47:240–43 doi:10.1161/STROKEAHA.115.010512 pmid:26534975

    Abstract/FREE Full Text
21. 21.↵
    2. Fujimura M,
    3. Funaki T,
    4. Houkin K, et al

    . Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset Moyamoya disease: case-control study of the Japan Adult Moyamoya Trial. J Neurosurg 2018 May 4:1–7. [Epub ahead of print] doi:10.3171/2017.11.JNS171990 pmid:29726780

    CrossRefPubMed
22. 22.↵
    2. Baltsavias G,
    3. Khan N,
    4. Valavanis A

    . The collateral circulation in pediatric Moyamoya disease. Childs Nerv Syst 2015;31:389–98 doi:10.1007/s00381-014-2582-5 pmid:25378261

    CrossRefPubMed
23. 23.↵
    2. Nelson MD Jr.,
    3. Gonzalez-Gomez I,
    4. Gilles FH

    . Dyke Award: the search for human telencephalic ventriculofugal arteries. AJNR Am J Neuroradiol 1991;12:215–22 pmid:1902016

    Abstract/FREE Full Text
24. 24.↵
    2. Mayer PL,
    3. Kier EL

    . The controversy of the periventricular white matter circulation: a review of the anatomic literature. AJNR Am J Neuroradiol 1991;12:223–28 pmid:1902017

    FREE Full Text
25. 25.↵
    2. Marinkovic S,
    3. Gibo H,
    4. Filipovic B, et al

    . Microanatomy of the subependymal arteries of the lateral ventricle. Surg Neurol 2005;63:451–58 doi:10.1016/j.surneu.2004.06.013 pmid:15883071

    CrossRefPubMed
26. 26.↵
    2. Sasagasako T,
    3. Funaki T,
    4. Tanji M, et al

    . Intractable medial anastomotic branches from the lenticulostriate artery causing recurrent hemorrhages in Moyamoya disease. World Neurosurg 2019;127:279–83 doi:10.1016/j.wneu.2019.04.066 pmid:30995561

    CrossRefPubMed
27. 27.↵
    2. Wang S,
    3. Lou M,
    4. Liu T, et al

    . Hematoma volume measurement in gradient echo MRI using quantitative susceptibility mapping. Stroke 2013;44:2315–17 doi:10.1161/STROKEAHA.113.001638 pmid:23704111

    Abstract/FREE Full Text